Inhaled Fluticasone PropionateA Pharmacoeconomic Review of its Use in the Management of Asthma

被引：0

作者：

Harriet M. Lamb

Christine R. Culy

Diana Faulds

机构：

[1] Adis International Limited,

来源：

PharmacoEconomics | 2000年 / 18卷

关键词：

Asthma; Budesonide; Fluticasone Propionate; Sodium Cromoglycate; Persistent Asthma;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：487 / 510

页数：23

共 50 条

[1] Inhaled Salmeterol/Fluticasone PropionateA Review of its Use in Asthma
Neil A. Reynolds
Katherine A. Lyseng-Williamson
Lynda R. Wiseman
Drugs, 2005, 65 : 1715 - 1734
[2] Inhaled fluticasone propionate - A pharmacoeconomic review of its use in the management of asthma
Lamb, HM
Culy, CR
Faulds, D
PHARMACOECONOMICS, 2000, 18 (05) : 487 - 510
[3] Inhaled salmeterol/fluticasone propionate combinationA pharmacoeconomic review of its use in the management of asthma
Katherine A. Lyseng-Williamson
Greg L. Plosker
PharmacoEconomics, 2003, 21 : 951 - 989
[4] Inhaled Salmeterol/Fluticasone Propionate CombinationA Pharmacoeconomic Review of its Use in the Management of Asthma
Anthony Markham
Julie C. Adkins
Blair Jarvis
PharmacoEconomics, 2000, 18 : 591 - 608
[5] Inhaled salmeterol/fluticasone propionate combination - A pharmacoeconomic review of its use in the management of asthma
Lyseng-Williamson, KA
Plosker, GL
PHARMACOECONOMICS, 2003, 21 (13) : 951 - 989
[6] Inhaled salmeterol/fluticasone propionate combination - A pharmacoeconomic review of its use in the management of asthma
Markham, A
Adkins, JC
PHARMACOECONOMICS, 2000, 18 (06) : 591 - 608
[7] Salmeterol/Fluticasone PropionateA Review of its Use in Asthma
Kate McKeage
Susan J. Keam
Drugs, 2009, 69 : 1799 - 1828
[8] Inhaled Salmeterol/Fluticasone PropionateA Review of its Use in Chronic Obstructive Pulmonary Disease
Caroline Fenton
Gillian M. Keating
Drugs, 2004, 64 : 1975 - 1996
[9] Inhaled salmeterol/fluticasone propionate - A review of its use in asthma
Reynolds, NA
Lyseng-Williamson, KA
Wiseman, LR
DRUGS, 2005, 65 (12) : 1715 - 1734
[10] Inhaled Fluticasone PropionateA Review of its Therapeutic Efficacy at Dosages ≤ 500 µg/day in Adults and Adolescents with Mild to Moderate Asthma
Blair Jarvis
Diana Faulds
Drugs, 1999, 57 : 769 - 803

← 1 2 3 4 5 →